Register Login

Spruce Biosciences Inc (SPRB)

Gharib Samir M. 🟡 adjusted position in 6.7K shares (3 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $88.41 Transaction Date: Dec 10, 2025 | Filing ID: 000007

Full text
Register to leave comments
  • News bot Dec. 13, 2025, 12:08 a.m.

    🔍 Gharib Samir M. (Executive)

    Company: SPRUCE BIOSCIENCES, INC. (SPRB)

    Report Date: 2025-12-10

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 10,014
    • Total shares sold: 3,278

    Detailed Transactions and Holdings:

    • Acquired 514 shares of Common Stock (Direct)
      Date: 2025-12-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,580.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 184 shares of Common Stock at $85.67 per share (Direct)
      Date: 2025-12-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,396.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,900 shares of Common Stock (Direct)
      Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,296.00 | transaction_form_type: 4 | Footnotes: F3, F2
    • Sold 680 shares of Common Stock at $88.41 per share (Direct)
      Date: 2025-12-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 7,616.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 514 shares of Restricted Stock Units (Derivative)
      Date: 2025-12-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,539.00 | transaction_form_type: 4 | Footnotes: F2, F1, F1
    • Acquired 7,600 shares of Restricted Stock Units (Derivative)
      Date: 2025-12-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,600.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
    • Sold 1,900 shares of Restricted Stock Units (Derivative)
      Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,700.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

    Footnotes:

    • F1: On March 14, 2024, the Reporting Person was granted a total of 2,053 RSU's. Subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date, 25% of the total number of RSUs vested on December 10, 2025, the first anniversary of the achievement of a specified clinical development objective. 25% of the total number of the RSUs will vest on each of the second, third and fourth anniversaries of such achievement. On December 10, 2025, 514 shares vested and 184 shares were withheld for taxes, resulting in a net issuance of 330 shares.
    • F2: Each RSU represents a contingent right to receive one share of SPRB common stock.
    • F3: 25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 1,900 shares vested and 680 shares were withheld for taxes, resulting in a net issuance of 1,220 shares.

Search

News categories